Reveleer
PrivateLast Round
Debt
Feb 26, 2024
Total Funding Raised
$153.1M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Reveleer operates in Healthcare & Life Sciences and is based in Glendale, California. Its latest recorded funding round was a Debt round in February 2024.
Reveleer is a healthcare technology company that provides an AI-powered data and analytics platform for health plans and providers to manage risk adjustment, quality improvement, and member management initiatives.
Sector
Healthcare & Life Sciences
Verticals
Healthcare Analytics, Workflow Automation, Medical AI, Revenue Cycle, Compliance & Risk
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Reveleer Comparables
Compare Reveleer with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Centauri Health Solutions | 84% | |
| Advantmed | 84% | |
| HealthEdge | 81% |
For institutional investors. Book with your work email.
Reveleer Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Feb 26, 2024 | ||||
| Series D | Dec 7, 2021 | ||||
| Series C | Jan 21, 2020 | ||||
| Series B | Nov 27, 2018 | ||||
| Series A | Feb 6, 2013 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Reveleer Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hercules Capital | Debt |
| Oak HC/FT | Series D |
| Upfront Ventures | Series D, Series A, Series C, Series B |
| Boston Millennia Partners | Series D, Series C |
| Redhills Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 12, 2026
Fadi Almachraki appointed as new CTO.
- Jul 27, 2026
Monthly visitors increased 44% MoM.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- hiresNov 12, 2026
Reveleer appoints Fadi Almachraki as Chief Technology Officer on Nov 12th '26 in California, where he leads software engineering, data science, AI, development operations, corporate IT, and information security.
- hiresOct 31, 2026
Reveleer hires Rajan as Human Resources Director from ValGenesis.
- hiresOct 15, 2026
Reveleer appoints Jean-Luc Neptune, MD, MBA, as Chief Medical Officer in California on Oct 15th '26, with Dr. Neptune leading clinical strategy across risk adjustment, quality, and member management programs serving 12 million covered lives.
- hiresOct 15, 2026
Reveleer appoints Jean-Luc ("JL") Neptune as Chief Medical Officer in California on Oct 15th '26, with Neptune leading clinical strategy across risk adjustment, quality, and member management programs serving 12 million covered lives.
For institutional investors. Book with your work email.
Reveleer Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Reveleer's valuation, stock price, and market status.
Is Reveleer a public or private company?
Reveleer is a private company.
What is the current stock price of Reveleer?
Reveleer is a private company, so its shares have no public market price. Caplight tracks Reveleer's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Reveleer worth (valuation)?
Valuation information for Reveleer is not publicly available.
Can I buy Reveleer stock?
Reveleer shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Reveleer's last funding round?
Reveleer's most recent funding round was Debt on February 26, 2024.
Who are the main investors in Reveleer?
Key investors in Reveleer include Hercules Capital, Oak HC/FT, Upfront Ventures, Boston Millennia Partners.
Will Reveleer IPO soon?
No public IPO plans have been announced for Reveleer.
How can I track Reveleer secondary market activity?
Caplight tracks bids, offers, and trades in Reveleer's shares on secondary markets.